Oxymax

Quick links to important sections

Oxymax

Method of action: Ophthalmologicals

Treatment option: Blepharitis, Keratitis, Trachoma

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Oxymax

Property Description
Active ingredient Oxytetracycline Hydrochloride
Pharmacological class Tetracycline-class Antimicrobial
Origin Semi-synthetic (derived from Streptomyces rimosus)
Primary Forms Oral Capsules/Tablets, Injectable Solutions, Topical Ointments
General Purpose Managing susceptible bacterial infections

What Type of Medicine Is Oxymax? (Identity and Classification)

Oxymax is the trade name for a pharmaceutical product whose active ingredient is Oxytetracycline Hydrochloride, which belongs to the Tetracycline-class Antimicrobial group of medicines. It is categorized as a broad-spectrum antibiotic because it is clinically recognized for its activity against a wide range of bacterial pathogens, including both Gram-positive and Gram-negative species.

This classification makes it a specialized tool for managing microbial threats across the body. Its use is distinct from other drug types, such as macrolides or penicillins. While typically indicated for infection management, Oxytetracycline has historically been used to treat conditions like certain skin infections. The medication is commonly supplied in multiple preparations, including oral solid forms (capsules or tablets), injectable solutions, and topical preparations.


Composition and Origin: The Active Ingredient's Foundation

The core substance, Oxytetracycline Hydrochloride, is a semi-synthetic compound, meaning its fundamental structure is derived from a natural source before chemical refinement. The base Oxytetracycline molecule is sourced from the fermentation products of the soil bacterium Streptomyces rimosus.

For stability and reliable therapeutic use, the substance is manufactured as the hydrochloride salt form, which significantly increases its solubility for consistent absorption in the body. This stable form is then combined with various pharmaceutical excipients appropriate for its final presentation, whether that is a solution base or a simple binder for tablets.


How Does Oxymax Address Bacterial Growth? (General Purpose)

The general therapeutic purpose of Oxymax is realized through its potent bacteriostatic effect on target microorganisms. This action involves the compound entering the bacteria and interfering with the synthesis of proteins essential for growth and replication.

By halting the progression and multiplication of the bacterial population, the medicine serves as a critical infection management tool. This suppression of growth provides the patient's own immune system with the necessary advantage to eliminate the now-static bacterial cells and facilitate the resolution of the illness.

Regulatory References

  1. Oxytetracycline Hydrochloride Capsule - DailyMed (NIH/NLM)

What side effects are possible with Oxymax?

Possible Side Effects and Safety Information

The safety profile of Oxytetracycline Hydrochloride, the active ingredient in Oxymax, is officially documented by government regulatory agencies and classified by the System-Organ Class (SOC) affected. The most frequently observed effects generally involve the Gastrointestinal system, often manifesting as nausea, vomiting, abdominal discomfort, and diarrhea. Another notable and commonly expected dermatological effect is photosensitivity, which involves an exaggerated sunburn reaction upon exposure to sunlight.


Serious Adverse Reactions and Systemic Concerns

Official labeling documents identify serious adverse reactions, which occur rarely but require attention. These include severe hypersensitivity reactions, such as anaphylaxis. Effects on the nervous system include the potential for Benign Intracranial Hypertension (pseudotumor cerebri). Severe hepatic injury is also documented as a possible hepatobiliary disorder. Like all broad-spectrum antimicrobials, a risk of superinfection (overgrowth of non-susceptible organisms) is associated, particularly with prolonged use.


Population-Specific Safety Constraints

Regulatory safety information outlines specific constraints for vulnerable groups. The medicine is generally contraindicated in children under 8 years of age due to the risk of permanent tooth discoloration and enamel hypoplasia, as well as potential effects on bone growth. Similarly, use is restricted during pregnancy and lactation due to documented risks to fetal skeletal and dental development. Caution is also required in individuals with renal impairment, as reduced clearance may increase systemic toxicity.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Oxytetracycline Hydrochloride (Oxymax) overdose centers on documented severe systemic manifestations and mandated emergency actions. Overdosage may lead to severe gastrointestinal symptoms, including anorexia, nausea, vomiting, and diarrhea. Of greater concern is the potential for Intracranial Hypertension (Pseudotumor Cerebri), which presents with neurological signs such as severe headache, blurred vision, and possible permanent visual loss. These manifestations signal the need for urgent clinical intervention.

Regulators emphasize that management must begin with the immediate discontinuation of the medication and the requirement to seek immediate medical advice. Treatment is strictly symptomatic and supportive, as there is no known specific antidote available. Monitoring requires attention to renal and hepatic function, and prompt ophthalmologic evaluation is warranted if visual disturbances occur. Patients with significantly impaired renal function are officially noted to be at greater risk for more severe outcomes due to increased systemic drug levels.

Therapeutic Uses of Oxymax

Oxymax is used in clinical settings that involve acute or unstable symptom patterns associated with certain distressing symptoms. Its therapeutic applications span multiple major systems and disease types.

Primary Therapeutic Support

This medication is applied across domains where additional symptomatic support is needed, primarily for conditions associated with acute or disruptive episodes caused by specific pathogens. These conditions generally include Rickettsial diseases (like Rocky Mountain spotted fever), Chlamydia and Mycoplasma infections, Acne vulgaris, and specific infections of the respiratory and urogenital systems. Used in settings marked by temporary physiological imbalance, it supports the patient during difficult episodes by easing distress and assists with maintaining functional stability.

“It is commonly used across conditions presenting with episodic or fluctuating manifestations, and may be part of symptomatic management in situations where patients experience sensitivities to other treatment options.”

For persistent skin issues, it is applied in addressing symptom clusters like papules and pustules, which provides support that helps ease the overall symptom burden. It is also applicable within clinical settings that involve acute symptom patterns affecting the eyes/ears and respiratory tract.

Quick Fact: Symptomatic Support
Primary Benefit Provides support that helps ease the overall symptom burden in conditions like chronic acne and acute systemic infections.
Symptom Focus Managing fever, malaise, and inflammatory skin lesions that create noticeable functional strain.
Clinical Use Relevant when supportive symptom management is appropriate, particularly in patients with allergies to penicillin-class drugs.

Eligibility and Restrictions for Use

Who Can and Cannot Use Oxymax?

Eligibility for Oxymax (Oxytetracycline Hydrochloride) is strictly defined by official regulatory documentation and based on population characteristics and pre-existing health conditions.


Contraindicated Populations (Must Not Use)

Oxymax is contraindicated (prohibited) for use in several specific populations:

  • Individuals with a known hypersensitivity or allergy to any drug in the tetracycline class.
  • Women in the last half of pregnancy (second and third trimesters) due to the documented risk of fetal skeletal and dental damage.
  • Children under 8 years of age (for systemic use) due to the risk of permanent tooth discoloration and enamel damage.
  • Patients with severe renal failure or severe hepatic failure.
  • Patients with Systemic Lupus Erythematosus or certain Porphyrin metabolism disorders.

Use with Restriction or Caution

Use is allowed under specific monitoring and caution for other groups:

Population Group Regulatory Status
Older Adults Requires special care due to potential for reduced renal function.
Non-Severe Renal/Hepatic Impairment Requires caution and monitoring due to risk of drug accumulation.
Lactating/Breastfeeding Women Not recommended as the drug is excreted in breast milk.

What should I know about interactions with other medicines?

Oxymax (Oxytetracycline Hydrochloride) has a regulatory interaction profile defined by combinations that must be avoided and specific constraints regarding co-administration.

Formal Contraindications and High-Risk Combinations

  • Retinoids (e.g., Isotretinoin, Acitretin): The co-administration of Oxytetracycline and Retinoids is officially contraindicated or advised to be avoided due to the risk of developing Intracranial Hypertension (pseudotumor cerebri).
  • Methoxyflurane: Concurrent use with this anesthetic agent is formally reported to result in fatal renal toxicity.
  • Penicillins: Co-administration is advised to be avoided because Oxytetracycline's bacteriostatic action may interfere with the bactericidal effect of penicillin-class drugs.

Pharmacokinetic Interference and Timing Rules

The primary pharmacokinetic interaction involves a reduction in serum concentration due to impaired absorption. This occurs with:

  • Cation-Containing Agents: Antacids (containing Aluminum, Calcium, or Magnesium salts), Iron-containing preparations, and Zinc supplements impair gastrointestinal absorption by chelation.
  • Timing Requirement: Regulatory documentation mandates that Oxytetracycline and these cation-containing preparations must be separated by an interval of at least two to four hours.
  • Food and Dairy Products: Absorption is similarly impaired when Oxytetracycline is taken with food, milk, or dairy products.

Pharmacodynamic Potentiation and Other Notes

  • Oral Anticoagulants: Tetracyclines are documented to depress plasma prothrombin activity, which may potentiate the effect of Coumarin-type anticoagulants.
  • Oral Contraceptives: Concurrent use may officially render oral contraceptives less effective.
  • Renal Impairment: Patients with significantly impaired renal function are at a greater risk for toxicity (e.g., azotemia) due to officially noted decreased drug clearance.

Mechanism of Action

The mechanism of Oxytetracycline Hydrochloride operates by highly selective interference with the essential cellular processes of susceptible bacteria, resulting in altered microbial growth dynamics.


Blocking the Bacterial Protein Synthesis Machinery

Oxytetracycline is an inhibitor that targets the bacterial 30S ribosomal subunit. It achieves a bacteriostatic effect by binding reversibly to the A (acceptor) site, physically preventing the attachment of aminoacyl-tRNA. This direct interference with the translation process inhibits the elongation of new protein chains, preventing the synthesis of essential proteins required for cellular growth and replication.


Modulation of Microbial Growth Dynamics and Immune Clearance

By arresting the proliferation and multiplication of the bacterial population, the mechanism is positioned to enable a host immune response. This suppression of microbial growth allows the body's natural defenses to facilitate the clearance of non-replicating cells by the host immune system.


Mechanistic Constraints and Overridden Efficacy

The function of the mechanism requires the drug reaching the target, which can be thwarted by bacterial defense mechanisms like Efflux Pumps or Ribosomal Protection Proteins that actively remove or dislodge the drug. Furthermore, the drug's activity can be chemically constrained by chelation with metal ions, reducing the amount of active agent available for uptake.

Dosage and Administration Information

How to Use Oxymax

The following information outlines the administration instructions for Oxymax.

Administration Overview

Oxymax is administered topically to the eye (ophthalmic use). The recommended dose is one drop instilled into the affected eye(s) once daily. Patients must use the medicine precisely as prescribed, without exceeding the maximum single-drop, once-daily schedule.

Administration Detail Official Instruction
Route of Administration Ophthalmic (Topical use in the eye)
Dosing Schedule One drop into the affected eye(s)
Frequency Once daily

Procedural Steps and Constraints

To ensure proper administration and hygiene, specific procedural steps must be followed:

  1. Preparation and Instillation: Remove the single-use container from its foil pouch immediately before use. Instill one drop into the affected eye(s), avoiding contact between the container tip and the eye or any other surface.
  2. Disposal: The single-use container must be discarded immediately after use, even if solution remains. Do not save an open container for later use.
  3. Contact Lenses: If you wear contact lenses, they must be removed before applying Oxymax. Wait at least 15 minutes after administration before reinserting the contact lenses.
  4. Other Eye Medications: If you use other topical eye products, they must be administered at least 15 minutes apart from the Oxymax dose.

Missed Dose Instructions

If a dose of Oxymax is missed, the patient should continue with the next scheduled dose on the following day. The maximum dose is one drop per day, and a double dose should not be taken to make up for a missed one.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Oxymax

Evidence for Use in Acne Vulgaris

Research has explored the compound for Acne vulgaris presenting with inflammatory lesions, a condition that was studied in research exploring how symptoms change over time. Studies primarily conducted in this area involve short-to-intermediate-term Randomized Controlled Trials (RCTs) and subsequent systematic reviews, where the medicine was evaluated against placebo or another study compound. Researchers focused on tracking the evolution of lesions like papules and pustules using standardized clinical assessment scales.

Findings from these studies describe patterns observed in the measured populations, noting how lesion counts evolved during the study period. These findings contribute to the broader evidence landscape for the compound in research exploring short-term symptom changes for this condition.

What remains uncertain is whether long-term outcomes following the completion of the study intervention are fully established. There is limited information for long-term outcomes regarding the evolution of symptom patterns over extended periods.

Evidence for Use in Acute Systemic Infections

Oxytetracycline has also been studied for conditions associated with acute or disruptive episodes caused by susceptible organisms, such as Rickettsial diseases and certain Chlamydia and Mycoplasma infections. Evidence for these uses is generally derived from a combination of older, pivotal controlled trials and observational settings. The main outcomes tracked included measures of symptom resolution (e.g., disappearance of fever) and microbiological measures related to the causative pathogen.

Data show patterns related to the medicine's evaluation as a compound studied in these conditions, particularly in research contexts involving fluctuating or unstable symptoms. Findings indicate that in specific settings, the compound was observed in studies involving patients with a history of allergic reactions, such as those to penicillin-class antimicrobials.

What is Still Uncertain About the Research

The research provides insight into short-term changes and contributes to the broader evidence landscape, but certainty remains low in several areas. Key research limitations include that results apply only to the populations studied, and comparative evidence is lacking against the newest therapeutic alternatives for every indication. Furthermore, research involving young children or pregnant populations has not been described, meaning the results apply only to the populations studied.

Key Studies & References

  1. Tetracyclines: MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Oxymax (FAQ)


Q: Is Oxymax a new type of drug, or has the active ingredient been around for a while?

A: The active ingredient in Oxymax, Oxytetracycline, is a long-established compound. Official information indicates it is a semi-synthetic substance, meaning its base structure is derived from the naturally occurring fermentation products of the soil bacterium Streptomyces rimosus.


Q: Does Oxymax cause drowsiness, making it difficult to drive or operate machinery?

A: Official documentation notes adverse effects on the nervous system, including reports of dizziness and headache, which are systemic effects. Regulatory documents describe the potential for dizziness or headache, and individuals typically review the full label information regarding operating machinery.


Q: Are there any common over-the-counter (OTC) pain relievers that interact with Oxymax?

A: Certain regulatory interaction checkers note no known drug-to-drug interaction between the active ingredient (Oxytetracycline) and common OTC pain relievers like acetaminophen (paracetamol). Information from official interaction checkers generally focuses on major drug-drug interactions documented in regulatory materials.


Q: Can I take Oxymax if I am also taking herbal supplements like St. John's Wort or Ginkgo Biloba?

A: Information regarding the entire tetracycline class of antibiotics suggests that co-administration with certain herbal supplements, such as St. John’s Wort or Dong Quai, may increase the potential for photosensitivity reactions (severe sunburn). This potential interaction is mentioned in reports describing data for the entire pharmacological class of the medication.


Q: Is there a specific food or drink, like grapefruit juice, that must be avoided while using Oxymax?

A: Official drug labels state that the medication’s absorption is officially impaired when taken with food, milk, or dairy products in general. Official labels generally focus on absorption impairment caused by food, milk, or dairy products, which contain certain cations.


Q: Can Oxymax be used long-term, or is it typically only prescribed for a short period?

A: Clinical research has primarily focused on short-to-intermediate-term use when evaluating the medicine’s effectiveness. Official documents note that information regarding the evaluation of long-term outcomes following extended periods of use remains limited.


Q: What happens in the body when Oxymax starts to leave the system?

A: According to pharmacokinetic descriptions, the active ingredient is incompletely absorbed from the gastrointestinal tract. The portion that is absorbed is primarily cleared by the kidney. The drug’s elimination half-life—the time required for the amount of active drug in the body to reduce by half—is noted to be approximately 10 to 17 hours.


Q: What is the difference between an intended use and an off-label use for Oxymax, according to official sources?

A: The intended use is defined strictly by the specific indications that are listed in the official regulatory documentation, such as the FDA label. Uses that are not listed in the official labeling are generally considered outside of the regulatory intended scope.


Q: Do official documents mention any potential long-term effects of using Oxymax?

A: Official research summaries describe studies that primarily evaluated short-to-intermediate-term changes in symptoms. Documentation indicates that certainty remains low regarding the full spectrum of long-term outcomes, such as how symptom patterns might evolve over extended periods following treatment.


Q: Is Oxymax known to affect fertility in men or women?

A: The active ingredient in Oxymax has been described in certain safety documentation as suspected of having reproductive toxicity based on available data. This is based on data where the compound was described as suspected of affecting fertility or the unborn child.


Q: What information is available about interactions between Oxymax and hormonal birth control?

A: Official documents explicitly state that concurrent use of the active ingredient with oral contraceptives may officially render them less effective. Regulatory documents indicate a potential for reduced effectiveness when co-administered with oral contraceptives.


Q: How does the elimination of Oxymax from the body happen, according to pharmacokinetics descriptions?

A: The elimination half-life for the active ingredient is noted to range between 10 and 17 hours, meaning the body takes this long to clear half of the drug from the system. The compound is mainly cleared by the kidney, and patients with kidney impairment may experience reduced clearance.


Q: Can taking Oxymax affect the results of routine lab tests, like cholesterol or glucose checks?

A: Official interaction information notes that the medication is documented to depress plasma prothrombin activity. This activity is a measure tracked in specific blood coagulation lab tests (related to clotting), and its change may affect the interpretation of those results.


Q: Are there any mental health side effects, such as mood changes or anxiety, associated with Oxymax?

A: The medication's documented adverse effects profile includes effects on the central nervous system. These reports involve severe headache, dizziness, and the potential for benign intracranial hypertension (increased pressure in the head). The regulatory adverse effects profile does not routinely feature mood changes or anxiety.

How should Oxymax be stored and disposed of?

Storage and Disposal Requirements

Oxymax (Oxytetracycline Hydrochloride) must be stored under specific conditions to maintain stability and prevent degradation. The medication must be kept at a controlled room temperature between 20 C to 25 C (68 F to 77 F). Storage areas must protect the product from light and moisture.

The oral form should remain in its original, tightly closed container at all times. Improper storage, especially high heat or humidity, is known to accelerate degradation in tetracycline-class drugs.

For safety, the medication must be kept out of the reach of children. Unused or expired Oxymax should be disposed of according to local regulations, typically through a drug take-back program. It must not be disposed of in wastewater to avoid environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Oxymax found in:

A-Z Index: